Results
1 -
10 of
13
(Click
here to explore results)
- New tricks for human farnesyltransferase inhibitor: cancer and beyond. Jingyuan Wang, Xue Yao, Jin Huang
, Med. Chem. Commun.
, 2017
, 8
, 841
- Prenyltransferase inhibitors: treating human ailments from cancer to parasitic infections. Joshua D. Ochocki, Mark D. Distefano
, Med. Chem. Commun.
, 2013
, 4
, 476
- Targeting coenzyme Q10 synthesis overcomes bortezomib resistance in multiple myeloma. Esther A. Zaal, Harm-Jan de Grooth, Inge Oudaert, Pieter Langerhorst, Sophie Levantovsky, Gijs J. J. van Slobbe, Jeroen W. A. Jansen, Eline Menu, Wei Wu, Celia R. Berkers
, Mol. Omics
, 2022
, 18
, 19
- Access to 3-spiroindolizines containing an isoindole ring through intra-molecular arylation of spiro-N-acyliminium species: a new family of potent farnesyltransferase inhibitors. Anthony Pesquet, Hamid Marzag, Michael Knorr, Carsten Strohmann, Ata Martin Lawson, Alina Ghinet, Joëlle Dubois, Farce Amaury, Adam Daïch, Mohamed Othman
, Org. Biomol. Chem.
, 2019
, 17
, 2798
- Synthetic applications of hypophosphite derivatives in reduction. Carole Guyon, Estelle Métay, Florence Popowycz, Marc Lemaire
, Org. Biomol. Chem.
, 2015
, 13
, 7879
- On the discovery of new potent human farnesyltransferase inhibitors: emerging pyroglutamic derivatives. Germain Homerin, Emmanuelle Lipka, Benoît Rigo, Amaury Farce, Joëlle Dubois, Alina Ghinet
, Org. Biomol. Chem.
, 2017
, 15
, 8110
- Discovery of novel inhibitors for human farnesyltransferase (hFTase) via structure-based virtual screening. Xiaojuan Yu, Xue Zhao, Lili Zhu, Chuanxin Zou, Xiaofeng Liu, Zhenjiang Zhao, Jin Huang, Honglin Li
, Med. Chem. Commun.
, 2013
, 4
, 962
- Benzylation of heterocyclic N-oxides via direct oxidative cross-dehydrogenative coupling with toluene derivatives. L. Wan, K. Qiao, X. N. Sun, Z. C. Di, Z. Fang, Z. J. Li, K. Guo
, New J. Chem.
, 2016
, 40
, 10227
- Advancement in methodologies for reduction of nitroarenes. Hari K. Kadam, Santosh G. Tilve
, RSC Adv.
, 2015
, 5
, 83391
- Novel quinoxaline-3-propanamides as VGFR-2 inhibitors and apoptosis inducers. Magda M. F. Ismail, Taghreed Z. Shawer, Rabab S. Ibrahim, Mostafa S. Abusaif, Mona M. Kamal, Rasha M. Allam, Yousry A. Ammar
, RSC Adv.
, 2023
, 13
, 31908